Purchase Order AG52KJP170031

Centrillion Technologies, Inc. was awarded a delivery order contract on June 27, 2017, for metagenomic sequencing services utilizing HiSeq Rapid 2x250 technology to process 18 samples. The contract, with a ceiling value of $24,895.00, is structured as a firm fixed-price delivery order and carries no set-aside designation. The work is being performed in Palo Alto, California, with an ultimate completion date of November 30, 2018. The funding source is identified as a civilian federal agency...

This $340,025 firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to Illumina, Inc. to deliver an Illumina NextSeq 2000 Sequencer or equivalent high-throughput next-generation sequencing system. The solicitation sought quotes for this sequencing equipment to increase NIAID's capacity for sequencing samples related to...

This $438,600 firm fixed price purchase order was awarded by the Department of Health and Human Services Food and Drug Administration to Pacific Biosciences of California, Inc. to deliver a SEQUEL IIE SYSTEM long-read DNA/RNA sequencing machine. The solicitation sought quotes for a turnkey sequencing solution to detect pathogen variants, access previously inaccessible genomic regions, and advance genetic research at the FDA's Center for Biologics Evaluation and Research Division of Cell and Gene...

The Department of Health and Human Services, National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) awarded a $1,485,085 firm-fixed-price purchase order to Illumina, Inc., a for-profit manufacturer of genomic sequencing systems and analytical instruments. The award is for the provision of one NovaSeq 6000 Sequencing System and associated warranty coverage, to support genomic sequencing efforts at the NIH's Stem Cell Translation Laboratory as part of...

The U.S. Army Materiel Command awarded a $389,909.00 firm fixed price purchase order to Illumina, Inc. for the delivery of one NextSeq 2000 sequencing system. This system is intended for high-volume sequencing applications and is expected to support whole genome, amplicon, RNA, and metagenomics sequencing with read lengths up to 150 base pairs. The award was made through a sole source procurement process, as the NextSeq 2000 is Illumina's proprietary sequencing platform. Illumina is a...

The Food and Drug Administration awarded a $534,031 firm fixed-price purchase order to Illumina, Inc. for one Illumina NextSeq 2000 High Throughput Next-Generation Sequencing System. This was a sole source award to the San Diego-based biotechnology company, with no set-aside designation applied. The equipment will be delivered to the FDA's facility in Silver Spring, Maryland, with a completion date of April 17, 2025. The Division of Applied Regulatory Science selected this system to enhance...

The Department of Health and Human Services' Food and Drug Administration awarded a $749,396.58 firm fixed price purchase order to Pacific Biosciences of California, Inc. to deliver a Versatile Sequencing II System. The sequencing system must be capable of producing long reads between 8,000 to over 20,000 bases, running a minimum of eight multiplexed samples simultaneously, and accommodating a cell confinement structure with 100,000 to 150,000 zero-mode waveguide holes, as specified in the...

This is a firm fixed price federal contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc. to provide the HiSeq 2500 sequencing system to the NHLBI Division of Intramural Research (DIR). The contract has a ceiling value of $647,403.80 and a period of performance ending on March 24, 2015. There is no set-aside designation associated with this award. Illumina, Inc. is a manufacturer and provider of...

The National Institutes of Health Clinical Center awarded a $279,999.93 firm-fixed price purchase order to Illumina, Inc. of San Diego, California. The contract calls for Illumina to provide two NextSeq 1000 Sequencing Systems to replace older equipment. The solicitation sought sequencing systems that could automatically generate DNA clusters and perform sequencing, primary, and secondary analysis compatible with existing assays, reagents, consumables, software, and workflows. As the only vendor...

This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Illumina, Inc. for the procurement of a NEXTSEQ 500 HIGH OUTPUT KIT (300 CYCLES) with a ceiling value of $77,520.00. The award was made on August 14, 2014 with a period of performance ending September 30, 2017. This award does not have a set-aside designation. Illumina, Inc. is a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis, and has a history of...